In clinical trials of the anti-inflammatory drug Inflaminex, adult and adolescent allergy patients were randomly divided...

In clinical trials of the anti-inflammatory drug Inflaminex, adult and adolescent allergy patients were randomly divided into two groups. Some patients received 500mcg of Inflaminex, while some patients received a placebo. Of the 2103 patients who received Inflaminex, 520 reported bloody noses as a side effect. Of the 1671 patients who received the placebo, 368 reported bloody noses as a side effect. Is there significant evidence to conclude that the proportion of Inflaminex users who experienced bloody noses as a side effect is greater than the proportion of the placebo group at the level of significance?

Solutions

Expert Solution

orchestra answered 1 year ago

Next > < Previous

Related Solutions

For the clinical trials of a weight-loss drug containing Garcinia Cambogia the subjects were randomly divided...

For the clinical trials of a weight-loss drug containing Garcinia Cambogia the subjects were randomly divided into two groups. The first received an inert pill along with an exercise and diet plan, while the second received the test medicine along with the same exercise and diet plan. The patients do not know which group they are in, nor do the fitness and nutrition advisors. a. Which is the treatment group? b. Which is the control group (if there is one)?...

A sample obese adult males were randomly divided into two groups in a clinical program. In...

A sample obese adult males were randomly divided into two groups in a clinical program. In the experimental group, participants were involved in a vigorous 30-minute-per-day exercise program and also given instructions on the importance of diet. The control group only received the diet instructions. The program directors want to determine if the exercise program had an impact on LDL cholesterol levels. Below are the LDL cholesterol data after one month in the program. What can be concluded with an...

In randomized, double-blind clinical trials of a new vaccine, infants were randomly divided into two groups....

In randomized, double-blind clinical trials of a new vaccine, infants were randomly divided into two groups. Subjects in group 1 received the new vaccine while subjects in group 2 received a control vaccine. After the second dose,114 of 726 subjects in the experimental group (group 1) experienced drowsiness as a side effect. After the second dose, 71 of 607 of the subjects in the control group (group 2) experienced drowsiness as a side effect. Does the evidence suggest that a...

In randomized, double-blind clinical trials of a new vaccine, monkeys were randomly divided into two groups....

In randomized, double-blind clinical trials of a new vaccine, monkeys were randomly divided into two groups. Subjects in group 1 received the new vaccine while subjects in group 2 received a control vaccine. After the second dose, 113 of 727 subjects in the experimental group (group 1) experienced drowsiness as a side effect. After the second dose, 70 of 608 of the subjects in the control group (group 2) experienced drowsiness as a side effect. Does the evidence suggest that...

In randomized, double blind clinical trials of a new vaccine,Monkeys were randomly divided into two groups.Subjects...

In randomized, double blind clinical trials of a new vaccine,Monkeys were randomly divided into two groups.Subjects in group x received the new vaccine while subject in group y received a control vaccine.After the first dose, 118 of 715 subjects in the experimental group ( group x) experienced fever as a side effect. After the first dose, 56 of 606 of the subjects in the control group ( group y ) experienced fever as a side effect.Construct a 90 % confidence...

A drug is used to help prevent blood clots in certain patients. In clinical trials, among 4244 patients treated with the drug

A drug is used to help prevent blood clots in certain patients. In clinical trials, among 4244 patients treated with the drug, 154 developed the adverse reaction of nausea. Construct a 99% confidence interval for the proportion of adverse reactions.a) Find the best point estimate of the population proportion p.nothing(Round to three decimal places as needed.)b) Identify the value of the margin of error E.E=nothing(Round to three decimal places as needed.)c) Construct the confidence interval.nothing<p<nothing(Round to three decimal places as...

The drug ancrod was tested in a double-blind clinical trial in which stroke patients were randomly...

The drug ancrod was tested in a double-blind clinical trial in which stroke patients were randomly assigned to receive either ancrod or a placebo. One of the response variables in the study was whether or not the subjects experienced intracranial hemorrhaging. Of the 84 patients who received ancrod, 13 hemorrhaged. Of the 77 patients who received the placebo, only three hemorrhaged. a.Is there a significant difference in hemorrhaging rates between treatments? Show your work and include all steps for full...

Lipitor is a cholesterol-reducing drug. In clinical trials, 94 subjects were treated with the drug and...

Lipitor is a cholesterol-reducing drug. In clinical trials, 94 subjects were treated with the drug and 200 were given a placebo. In the 94 subjects that received the treatment, 8 developed infections while in the placebo group of 200 there were 12 that developed an infection. At α=.05, is there a greater risk of infection from using Lipitor? Assume that P1 is the Percentage of Lipitor users that developed an infection. 1. What is the null hypothesis? 2. What is...

As a new targeted anti-cancer drug ‘FCIC-17’ enters Phase III clinical trials, it is determined that...

As a new targeted anti-cancer drug ‘FCIC-17’ enters Phase III clinical trials, it is determined that the drug requires hepatic activation in order to elicit a therapeutic effect. Further studies identify that the sole enzyme involved in the activation of this drug is CYP2C19. Questions: a) Select ONE specific factor (from the categories environmental, genetic or physiological) that may contribute to inter-individual variability in the activation of ‘FCIC-17’, and explain the potential consequences of this variability in terms of treatment...

Discuss the clinical uses and potential effects associated with anti-inflammatory,costicosteroids, and anti-gout drugs.

Subjects